# Pulmonx Corp: filings

LUNG · Nasdaq · CIK 1127537 · [Healthcare](/sectors/healthcare.md) · fiscal year ends Dec 31

Pages: [Overview](/companies/lung.md) · [Financials](/companies/lung/financials.md) · [Filings](/companies/lung/filings.md) · [Insiders](/companies/lung/insiders.md)

## Reports and events: 76 filings

Newest first, by EDGAR acceptance time (Eastern). Filter with ?form= one of: `periodic`, `8-K`, `10-K`, `10-Q`, `4`, `proxy`, `13dg`, `all`, or any form this company filed (4 197, 8-K 40, 144 30, SC 13G/A 21, 10-Q 18, 3 17, SC 13G 11, S-8 9, SCHEDULE 13G/A 9, 4/A 7, 10-K 6, D 6, DEF 14A 6, DEFA14A 6, CORRESP 5, D/A 5, ARS 4, SD 4, EFFECT 3, S-1/A 3, UPLOAD 3, 3/A 2, DRS 2, DRS/A 2, S-1 2, S-3 2, S-3/A 2, 424B4 1, 5 1, 8-A12B 1, 8-K/A 1, CERT 1, FWP 1, RW 1, SCHEDULE 13G 1).

| Filed | Accepted | Form | What it is | Accession |
| --- | --- | --- | --- | --- |
| 2026-10-27 | 16:07 ET | [8-K](/filings/0001127537-26-000042.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001127537-26-000042 |
| 2026-08-04 | 16:46 ET | [10-Q](/filings/0001127537-26-000039.md) | Quarterly report, period 2026-06-30 | 0001127537-26-000039 |
| 2026-07-29 | 16:07 ET | [8-K](/filings/0001127537-26-000035.md) | 2.02 Results of operations | 0001127537-26-000035 |
| 2026-06-04 | 16:04 ET | [8-K](/filings/0001127537-26-000031.md) | 5.07 Shareholder vote results | 0001127537-26-000031 |
| 2026-05-04 | 16:32 ET | [10-Q](/filings/0001127537-26-000025.md) | Quarterly report, period 2026-03-31 | 0001127537-26-000025 |
| 2026-04-29 | 16:13 ET | [8-K](/filings/0001127537-26-000020.md) | 2.02 Results of operations | 0001127537-26-000020 |
| 2026-04-22 | 16:07 ET | [DEF 14A](/filings/0001140361-26-016105.md) | Proxy statement, period 2026-06-04 | 0001140361-26-016105 |
| 2026-03-10 | 17:03 ET | [10-K](/filings/0001127537-26-000015.md) | Annual report, period 2025-12-31 | 0001127537-26-000015 |
| 2026-03-05 | 19:10 ET | [8-K](/filings/0001193125-26-092064.md) | 1.01 Entry into a material agreement; 1.02 Termination of a material agreement; 2.03 New direct financial obligation; 3.02 Unregistered sale of equity; 9.01 Financial statements and exhibits | 0001193125-26-092064 |
| 2026-03-04 | 16:11 ET | [8-K](/filings/0001127537-26-000003.md) | 2.02 Results of operations | 0001127537-26-000003 |
| 2025-11-12 | 16:25 ET | [10-Q](/filings/0001127537-25-000059.md) | Quarterly report, period 2025-09-30 | 0001127537-25-000059 |
| 2025-11-12 | 16:05 ET | [8-K](/filings/0001127537-25-000058.md) | 2.02 Results of operations | 0001127537-25-000058 |
| 2025-10-27 | 16:05 ET | [8-K](/filings/0001127537-25-000052.md) | 2.02 Results of operations; 5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits | 0001127537-25-000052 |
| 2025-08-01 | 17:16 ET | [10-Q](/filings/0001127537-25-000045.md) | Quarterly report, period 2025-06-30 | 0001127537-25-000045 |
| 2025-07-30 | 16:06 ET | [8-K](/filings/0001127537-25-000041.md) | 2.02 Results of operations | 0001127537-25-000041 |
| 2025-05-23 | 17:55 ET | [8-K](/filings/0001127537-25-000028.md) | 5.07 Shareholder vote results | 0001127537-25-000028 |
| 2025-05-02 | 16:18 ET | [10-Q](/filings/0001127537-25-000026.md) | Quarterly report, period 2025-03-31 | 0001127537-25-000026 |
| 2025-04-30 | 16:10 ET | [8-K](/filings/0001127537-25-000023.md) | 2.02 Results of operations | 0001127537-25-000023 |
| 2025-04-08 | 16:01 ET | [DEF 14A](/filings/0001140361-25-012814.md) | Proxy statement, period 2025-05-22 | 0001140361-25-012814 |
| 2025-02-25 | 16:27 ET | [10-K](/filings/0001127537-25-000012.md) | Annual report, period 2024-12-31 | 0001127537-25-000012 |
| 2025-02-19 | 16:09 ET | [8-K](/filings/0001127537-25-000003.md) | 2.02 Results of operations | 0001127537-25-000003 |
| 2024-11-01 | 16:23 ET | [10-Q](/filings/0001127537-24-000087.md) | Quarterly report, period 2024-09-30 | 0001127537-24-000087 |
| 2024-10-30 | 16:10 ET | [8-K](/filings/0001127537-24-000082.md) | 2.02 Results of operations | 0001127537-24-000082 |
| 2024-08-02 | 16:27 ET | [10-Q](/filings/0001127537-24-000077.md) | Quarterly report, period 2024-06-30 | 0001127537-24-000077 |
| 2024-07-31 | 16:10 ET | [8-K](/filings/0001127537-24-000073.md) | 2.02 Results of operations | 0001127537-24-000073 |
| 2024-05-23 | 16:24 ET | [8-K](/filings/0001127537-24-000063.md) | 1.01 Entry into a material agreement; 9.01 Financial statements and exhibits | 0001127537-24-000063 |
| 2024-05-17 | 16:03 ET | [8-K](/filings/0001127537-24-000057.md) | 5.07 Shareholder vote results | 0001127537-24-000057 |
| 2024-05-03 | 16:13 ET | [10-Q](/filings/0001127537-24-000052.md) | Quarterly report, period 2024-03-31 | 0001127537-24-000052 |
| 2024-05-01 | 16:10 ET | [8-K](/filings/0001127537-24-000045.md) | 2.02 Results of operations | 0001127537-24-000045 |
| 2024-04-05 | 16:08 ET | [DEF 14A](/filings/0001140361-24-018313.md) | Proxy statement, period 2024-05-16 | 0001140361-24-018313 |
| 2024-04-02 | 16:08 ET | [8-K](/filings/0001127537-24-000039.md) | 5.02 Departure or appointment of officers or directors; 8.01 Other events; 9.01 Financial statements and exhibits | 0001127537-24-000039 |
| 2024-02-27 | 16:07 ET | [10-K](/filings/0001127537-24-000024.md) | Annual report, period 2023-12-31 | 0001127537-24-000024 |
| 2024-02-21 | 16:08 ET | [8-K](/filings/0001127537-24-000013.md) | 2.02 Results of operations | 0001127537-24-000013 |
| 2024-02-21 | 16:05 ET | [8-K](/filings/0001127537-24-000012.md) | 5.02 Departure or appointment of officers or directors; 8.01 Other events; 9.01 Financial statements and exhibits | 0001127537-24-000012 |
| 2023-11-03 | 16:04 ET | [10-Q](/filings/0001127537-23-000048.md) | Quarterly report, period 2023-09-30 | 0001127537-23-000048 |
| 2023-10-30 | 16:06 ET | [8-K](/filings/0001127537-23-000042.md) | 2.02 Results of operations | 0001127537-23-000042 |
| 2023-10-10 | 16:06 ET | [8-K](/filings/0001193125-23-253468.md) | 2.02 Results of operations; 5.02 Departure or appointment of officers or directors; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001193125-23-253468 |
| 2023-08-04 | 16:21 ET | [10-Q](/filings/0001127537-23-000036.md) | Quarterly report, period 2023-06-30 | 0001127537-23-000036 |
| 2023-08-02 | 16:06 ET | [8-K](/filings/0001127537-23-000032.md) | 2.02 Results of operations | 0001127537-23-000032 |
| 2023-05-18 | 16:09 ET | [8-K](/filings/0001127537-23-000023.md) | 5.07 Shareholder vote results | 0001127537-23-000023 |
| 2023-05-08 | 17:12 ET | [10-Q](/filings/0001127537-23-000018.md) | Quarterly report, period 2023-03-31 | 0001127537-23-000018 |
| 2023-05-02 | 16:09 ET | [8-K](/filings/0001127537-23-000014.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001127537-23-000014 |
| 2023-04-04 | 16:40 ET | [DEF 14A](/filings/0001193125-23-090955.md) | Proxy statement, period 2023-05-17 | 0001193125-23-090955 |
| 2023-03-01 | 16:08 ET | [10-K](/filings/0001127537-23-000011.md) | Annual report, period 2022-12-31 | 0001127537-23-000011 |
| 2023-02-22 | 16:06 ET | [8-K](/filings/0001127537-23-000005.md) | 2.02 Results of operations; 2.03 New direct financial obligation; 9.01 Financial statements and exhibits | 0001127537-23-000005 |
| 2022-11-08 | 16:26 ET | [10-Q](/filings/0001127537-22-000053.md) | Quarterly report, period 2022-09-30 | 0001127537-22-000053 |
| 2022-11-03 | 16:03 ET | [8-K](/filings/0001127537-22-000048.md) | 1.01 Entry into a material agreement; 2.02 Results of operations | 0001127537-22-000048 |
| 2022-08-08 | 16:28 ET | [10-Q](/filings/0001127537-22-000037.md) | Quarterly report, period 2022-06-30 | 0001127537-22-000037 |
| 2022-08-02 | 16:11 ET | [8-K](/filings/0001127537-22-000033.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001127537-22-000033 |
| 2022-05-27 | 16:31 ET | [8-K](/filings/0001127537-22-000029.md) | 5.07 Shareholder vote results | 0001127537-22-000029 |

Page 1 of 2. [Older](/companies/lung/filings.md?page=2)
Source: SEC EDGAR, the company’s filing index. Last ingested by Listed: Oct 27, 2026, 16:08 ET. No prices; not investment advice.